Raising alarming concerns, dialysis kits imported from Thailand and supplied to government hospitals across Madhya Pradesh ...

MastCURe, a high-profile research consortium, has been awarded EUR1.3M in funding from the Eureka Eurostars program. The collaboration comprising Allegria Therapeutics, Cube Biotech, and the ...

Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...

Discover the top 10 weight loss medications of 2026. Explore how advanced GLP-1 therapies and combination drugs are reshaping ...

A research team at Leipzig University has identified a mechanism in adhesion G protein-coupled receptors (adhesion GPCRs), a ...

Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™,the scientifically-proven beverage proven to ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about ...

The Food and Drug Administration has announced a voluntary recall of select lots of Xanax. The incredibly popular ...

Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong ...

Backed by Apollo Health Ventures, Nula aims to transform treatment of metabolic dysfunction; ARPA-Hawardbringstotalfundingtomorethan$30million; Company plans to initiate Phase 1b ...

New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...